Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia. The defibrillation procedure encompasses delivery of an electric shock to the heart, which depolarizes heart muscles and restores its normal electric impulse. Growing focus towards public access defibrillator (PAD) by the public & private organizations, along with the key players, has fuelled the market growth. Other factors such as technologically advanced defibrillator devices, rapidly growing geriatric population with elevated risk of targeted diseases, and increasing incidence of cardiac diseases are driving the market growth. However, frequent product recalls, increasing pricing pressure on players and lack of awareness about sudden cardiac arrest (SCA) are restraining the growth of this market.
Browse the full report http://www.orbisresearch.com/reports/index/defibrillators-market-by-product-t-icds-s-icds-crt-d-med-aed-wcd-and-end-user-hospitals-prehospital-public-access-alternate-care-home-global-opportunity-analysis-and-industry-forecasts-2014-2022 .
The world defibrillators market is segmented on the basis of product, end user, and geography. On the basis of product, the world defibrillator market is further segmented into implantable defibrillators and external defibrillators. Implantable defibrillators are further categorized into cardiac resynchronisation therapy- defibrillator (CRT-D), transvenous implantable cardioverter defibrillator (T-ICDs) and subcutaneous implantable cardioverter defibrillator (S-ICDs). Among these, the T-ICDs segment dominates the overall ICD market owing to higher precision and targeted functioning. In addition, external defibrillators segment is further categorized into manual external defibrillator, automated external defibrillator (AEDs), and wearable cardioverter defibrillator (WCDs).
Check Discount For This Report http://www.orbisresearch.com/contacts/discount/225890 .
On the basis of end user, the defibrillator market is segmented into hospitals, prehospital, public access market, alternative care market, and home. Geographically, the market is segmented across four major regions such as North America, Europe, Asia-Pacific, and LAMEA. North America accounted for the largest market share in the defibrillators market. The growth in this region is mainly due to factors such as product innovations, growing number of public defibrillation programs, and rising prevalence of chronic diseases. In addition, the Asia-Pacific region is expected to emerge as the area with maximum growth potential due to the growing focus of key players in emerging economies, improving healthcare infrastructure, and rising number of cardiovascular diseases.
Purchase a copy of this report @ http://www.orbisresearch.com/contact/purchase/225890 .
The report provides a comprehensive analysis of the key players operating in the world defibrillators market such as Asahi Kasei Corporation, Stryker Corporation, Biotronik SE & Co. KG, Boston Scientific Corporation, Philips Healthcare, LivaNova PLC, Medtronic plc, Cardiac Science Corporation, Nihon Kohden Corporation, and St. Jude Medical, Inc.
For more information contact email@example.com
1 Asahi Kasei Corporation
1.1 Company Overview
1.2 Company Snapshot
1.3 Operating Business Segments
1.4 Business Performance
1.5 Key Strategic Moves and Developments
1.6 SWOT Analysis
2 Stryker Corporation
2.1 Company Overview
2.2 Company Snapshot
2.3 Operating Business Segments
2.4 Business Performance
2.5 Key Strategic Moves and Development
2.6 SWOT Analysis
3 Biotronik SE & Co. KG
3.1 Company Overview
3.2 Company Snapshot
3.3 Operating Business Segments
3.4 Key Strategic Moves & Developments
3.5 SWOT Analysis
4 Boston Scientific Corporation
4.1 Company Overview
4.2 Company Snapshot
4.3 Operating Business Segments
4.4 Business Performance
4.5 Key Strategic Moves and Developments
4.6 SWOT Analysis
5 Philips Healthcare (A Division of Koninklijke Philips N.V.)
5.1 Company Overview
5.2 Company Snapshot
5.3 Operating Business Segments Overview
5.4 Business Performance
5.5 SWOT Analysis
6 LivaNova PLC
6.1 Company Overview
6.2 Company Snapshot
6.3 Operating Business Segments
6.4 Business Performance
6.5 Key Strategic Moves and Developments
6.6 SWOT Analysis
7 Medtronic PLC
1 Company Overview
2 Company Snapshot
3 Operating Business Segments
4 Business Performance
5 Key Strategic Moves and Developments
6 SWOT Analysis
8 St. Jude Medical, Inc.
8.1 Company Overview
8.2 Company Snapshot
8.3 Operating Business Segments
8.4 Business Performance
8.5 Key Strategic Moves and Developments
8.6 SWOT Analysis
9 Cardiac Science Corporation
9.1 Company Overview
9.2 Company Snapshot
9.3 Operating Business Segments
9.4 Key Strategic Moves and Developments
9.5 SWOT Analysis
10 Nihon Koden Corporation
10.1 Company Overview
10.2 Company Snapshot
10.3 Operating Business Segments
10.4 Business Performance
10.5 Key Strategic Moves and Developments
10.6 SWOT Analysis
Request a sample of this report @ http://www.orbisresearch.com/contacts/request-sample/225890 .
Key Benefits for Stakeholders:
The study provides an in-depth analysis of the world neuromodulation market with current trends and future estimations to elucidate the imminent investment pockets.
The report provides a quantitative analysis from 2014 to 2022, which is expected to enable the stakeholders to capitalize on prevailing market opportunities.
The report provides actual historical figures for 2014 and 2015 and provides Y-o-Y forecasts for 2016 to 2022, considering 2015 as base.
Extensive analysis by product helps in understanding the various types of devices used for the treatment of neurological diseases and other related conditions.
Competitive intelligence highlights the business practices followed by leading players across various regions.
SWOT analysis studies the internal environment of the leading companies for strategy formulation.
For any enquires before buying, connect with us @ firstname.lastname@example.org